Nisha De Silva

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · New England Journal of Medicine · 2023 · 268 citations · Full text

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Moritz Fürstenau, Petra Langerbeins, Nisha De Silva et al. · Leukemia · 2020 · 45 citations · Full text

Clinical Infectious Disease, Covid-19 Pandemic, Immunology +7

Long Term Follow‐up Data and Health‐Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)

Nadine Kutsch, Jasmin Bahlo, Sandra Robrecht et al. · HemaSphere · 2020 · 44 citations · Full text

Quality Of Life, Mixed-phenotype Acute Leukemia, Pharmacotherapy +19

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

Moritz Fürstenau, Yvonne J. Thus, Sandra Robrecht et al. · Blood · 2023 · 35 citations · Full text

A Randomized Phase III Study of Venetoclax-Based Time-Limited Combination Treatments (RVe, GVe, GIVe) Vs Standard Chemoimmunotherapy (CIT: FCR/BR) in Frontline Chronic Lymphocytic Leukemia (CLL) of Fit Patients: First Co-Primary Endpoint Analysis of the International Intergroup GAIA (CLL13) Trial

Barbara Eichhorst, Carsten Utoft Niemann, Arnon P. Kater et al. · Blood · 2021 · 33 citations